Pankaj R Patel, Chairman of Zydus Lifesciences, envisions India delivering 100 new drugs by 2047, highlighting the importance of research, innovation, and capable human resources. He addressed myths ...

Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion ...

President Donald Trump escalated trade tensions Tuesday by threatening to impose new 25% tariffs on automobiles, ...

Pancreatic cancer, one of the most aggressive and lethal types of cancer, continues to present significant challenges in both its detection and treatment. The lack of early detection tools, coupled ...

We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...

A crucial challenge in AI today is bridging the gap between general intelligence and deep, organisation-specific knowledge.

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonisation. While ...

While addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardisation and regulatory convergence. She highlighted India's role as the "Pharmacy of the World ...